| 1 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D01227
D01227
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
| 2 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07077
D07077
|
Ambrisentan
| 7件: 51 51, 84, 85, 86, 88, 210, 211 |
| 3 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07171
D07171
|
Sitaxentan
| 1件: 86 86 |
| 4 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07538
D07538
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
| 5 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07741
D07741
|
Zibotentan
| 1件: 51 51 |
| 6 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D10135
D10135
|
Macitentan
| 5件: 51 51, 85, 86, 88, 210 |
| 7 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D11776
D11776
|
Sparsentan
| 3件: 66 66, 218, 222 |
| 8 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D01227
D01227
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
| 9 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D07538
D07538
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
| 10 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D10135
D10135
|
Macitentan
| 5件: 51 51, 85, 86, 88, 210 |
| 11 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D01977
D01977
|
Gefitinib
| 1件: 75 75 |
| 12 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D03455
D03455
|
Cetuximab
| 5件: 34 34, 51, 86, 89, 331 |
| 13 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D04023
D04023
|
Erlotinib
| 1件: 94 94 |
| 14 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D04024
D04024
|
Lapatinib
| 3件: 34 34, 74, 75 |
| 15 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D07907
D07907
|
Erlotinib
| 1件: 94 94 |
| 16 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
| 17 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D11251
D11251
|
Icotinib
| 1件: 34 34 |
| 18 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
| 19 |
EPHA2
| 5件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Axon guidance 💬 | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
| 20 |
EPHA2
| 5件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Axon guidance 💬 | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
| 21 |
ELANE
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Transcriptional misregulation in cancer 💬, Systemic lupus erythematosus 💬 | D03788
D03788
|
Sivelestat
| 3件: 13 13, 85, 96 |
| 22 |
EPHB4
| 1件: Axon guidance Axon guidance 💬 | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
| 23 |
EPOR
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 | D03231
D03231
|
Erythropoietin
| 10件: 2 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 |
| 24 |
EPOR
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 | D09946
D09946
|
Peginesatide
| 1件: 283 283 |
| 25 |
ERBB2
| 22件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, Platinum drug resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Tight junction 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Prostate cancer 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬 | D04024
D04024
|
Lapatinib
| 3件: 34 34, 74, 75 |
| 26 |
ERBB2
| 22件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, Platinum drug resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Tight junction 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Prostate cancer 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬 | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
| 27 |
ERBB2
| 22件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, Platinum drug resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Tight junction 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Prostate cancer 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬 | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
| 28 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00105
D00105
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 29 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00185
D00185
|
Estriol
| 2件: 13 13, 227 |
| 30 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00289
D00289
|
Danazol
| 5件: 60 60, 63, 64, 65, 285 |
| 31 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00554
D00554
|
Ethinylestradiol
| 4件: 13 13, 46, 49, 299 |
| 32 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00575
D00575
|
Mestranol
| 2件: 46 46, 49 |
| 33 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00962
D00962
|
Clomifene
| 1件: 74 74 |
| 34 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00966
D00966
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
| 35 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01161
D01161
|
Fulvestrant
| 2件: 49 49, 86 |
| 36 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01413
D01413
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 37 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01413
D01413
|
Estradiol valerate
| 1件: 65 65 |
| 38 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01617
D01617
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 39 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01953
D01953
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 40 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01986
D01986
|
Estriol
| 2件: 13 13, 227 |
| 41 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D02217
D02217
|
Raloxifene
| 1件: 46 46 |
| 42 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D02367
D02367
|
Desogestrel
| 1件: 230 230 |
| 43 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04061
D04061
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 44 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04063
D04063
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 45 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04064
D04064
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 46 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04065
D04065
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 47 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D07726
D07726
|
Clomifene
| 1件: 74 74 |
| 48 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08409
D08409
|
Prasterone
| 6件: 49 49, 53, 83, 86, 96, 113 |
| 49 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08465
D08465
|
Raloxifene
| 1件: 46 46 |
| 50 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08559
D08559
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
| 51 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D11513
D11513
|
Estetrol
| 1件: 53 53 |
| 52 |
ESR1
| 9件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D11514
D11514
|
Estetrol
| 1件: 53 53 |
| 53 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00105
D00105
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 54 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00185
D00185
|
Estriol
| 2件: 13 13, 227 |
| 55 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00575
D00575
|
Mestranol
| 2件: 46 46, 49 |
| 56 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00962
D00962
|
Clomifene
| 1件: 74 74 |
| 57 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D00966
D00966
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
| 58 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01161
D01161
|
Fulvestrant
| 2件: 49 49, 86 |
| 59 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01413
D01413
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 60 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01413
D01413
|
Estradiol valerate
| 1件: 65 65 |
| 61 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01617
D01617
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 62 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01953
D01953
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 63 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D01986
D01986
|
Estriol
| 2件: 13 13, 227 |
| 64 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D02217
D02217
|
Raloxifene
| 1件: 46 46 |
| 65 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04061
D04061
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 66 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04063
D04063
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 67 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04064
D04064
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 68 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D04065
D04065
|
Estradiol
| 7件: 13 13, 46, 49, 65, 76, 226, 299 |
| 69 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D07726
D07726
|
Clomifene
| 1件: 74 74 |
| 70 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08409
D08409
|
Prasterone
| 6件: 49 49, 53, 83, 86, 96, 113 |
| 71 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08465
D08465
|
Raloxifene
| 1件: 46 46 |
| 72 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D08559
D08559
|
Tamoxifen
| 4件: 2 2, 86, 113, 227 |
| 73 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D11513
D11513
|
Estetrol
| 1件: 53 53 |
| 74 |
ESR2
| 7件: Endocrine resistance Endocrine resistance 💬, Estrogen signaling pathway 💬, Prolactin signaling pathway 💬, GnRH secretion 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Breast cancer 💬 | D11514
D11514
|
Estetrol
| 1件: 53 53 |
| 75 |
ENPP2
| 2件: Ether lipid metabolism Ether lipid metabolism 💬, Metabolic pathways 💬 | D11844
D11844
|
Ziritaxestat
| 2件: 51 51, 85 |